January 30, 2019
Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)
Read More
December 10, 2018
Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Read More
December 10, 2018
A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622
Read More
X